Omivera
Latest round
- Seed
Last raised
- Feb 2026
Total raised
- $0.4M
Investors
- 1
About Omivera
V. operates a specialized platform focused on kinase selectivity and target engagement assessment. The company was formed to support drug discovery and development processes. Located at the Leiden Bio Science Park, Omivera is positioned within a prominent life sciences hub in Europe.V. Utilizing proprietary molecular probes and advanced proteomics techniques, CellEKT measures interactions with over 90% of the expressed kinome and various potential non-kinase off-targets.Omivera generates revenue through its CellEKT platform, offered as a contract research organization (CRO) service to pharmaceutical and biotech partners. The company engages clients in service agreements for comprehensive data analysis concerning drug selectivity and target engagement. Revenue is derived from fees associated with individualized studies or service packages, reflecting a B2B transaction structure.V. The company is focused on enhancing this platform and expanding its reach in the pharmaceutical and biotechnology sectors. Future strategies include exploring new geographic markets, aiming for a broader presence in Europe and North America, to be implemented by the end of 2026.
Who invested in Omivera
1 investor across 1 round
See all investors in Omivera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 12, 2026
Amount
$0.4M
Investors
Questions about Omivera
Who invested in Omivera?
Omivera has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Omivera raised?
Omivera has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Omivera last raise money?
Omivera's most recent round on record is a Seed, in Feb 2026.
What does Omivera do?
Omivera is a biotechnology company.
Where is Omivera headquartered?
Omivera is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Omivera?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Omivera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Omivera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.